Академический Документы
Профессиональный Документы
Культура Документы
com
Colorectal cancer
Open Access
being subjected to major total mesorectal excision that could result in greater numbers of patients undergo-
(TME) surgery, permanent stomas and even preopera- ing organ preservation.
tive radiotherapy despite early disease; the National
Bowel Cancer Audit (NBOCAP report, 2015)2 showed
that a significant proportion of patients with ERC had MATERIAL AND METHODS
T1N0 disease, yet underwent major resection surgery Study design
without any option for less radical treatments. Our study protocol was prospectively registered with our
Conversely, the UK transanal endoscopic microsurgery local research and development office and approved as
(TEM) database suggests that ∼30% of tumour consid- a service evaluation project. We reviewed our prospect-
ered as ERC based on clinical endoscopic assessment ively collected and scored database of imaging and path-
had more advanced disease, with evidence of spread ology records between 2010 and 2014. Since the data
beyond the muscularis propria (MP) on histopathology had been recorded prospectively prior to MDT and sur-
following TEM excision. No significant difference has gical resection, the scans were centrally reviewed by a
been found in the depth of TEM excision or R1 rate consultant radiologist (observer 1) with more than
between the patients who underwent endoluminal ultra- 15 years of gastrointestinal (GI) radiology experience
sound (EUS) before TEM and those who did not who was blinded to final histopathology data. Results of
( p=0.73) with EUS understaging taking place in 32.7% the prospectively collected MRI reports were compared
of patients.3 Therefore, the current standards of endo- with final histopathology of the resected specimens. All
scopic and EUS assessment appear insufficient to iden- MRIs were scored separately by a second radiologist
tify patients suitable for potentially less radical treatment (observer 2) with 8 years of GI radiology experience.
and the lack of any current robust preoperative staging
method means that decision and discussion of such Participants
treatment options cannot currently be offered The Royal Marsden Hospital Rectal Cancer database was
consistently. used to identify patients with rectal cancer staged by
The national SPECC (Significant Polyp and Early MRI as ≤T3b. Inclusion criteria were as follows: patients
Colorectal Cancer) initiative was a consequence of a under 18, had rectal cancer MRI staging and underwent
major problem we are currently facing—an overtreat- surgical resection. Patients were excluded if they: had
ment and undertreatment of ERC/significant polyps. other primary cancers found at or before diagnosis, if
MRI has largely been disregarded as a method of staging no preoperative MRI was available or preoperative MRI
ERC; however, the majority of publications have reported T stage was >T3b, mrCRM and mrEMVI positivity, or if
that MRI is not as useful compared with EUS for staging they received any preoperative therapy.
these lesions, although this has not been supported by
significant evidence in either direction.4–7 In the late
1990s, a high-resolution technique for staging advanced Test methods
rectal cancers and the principles for staging advanced Since 2010, our policy was to report ERC using a specific
rectal cancers were developed that enabled identifying reporting pro forma. Tumours staged as T2 or less were
the layers of the rectal wall with sufficient resolution to prospectively documented using the following ‘sm’
assess the submucosa and the MP.8 In subsequent studies, classification:
when formally compared with pathology, the depth of ▸ no MR-macroscopic evidence of submucosal invasion
spread on MRI has been found to agree with the corre- —benign polyp;
sponding histopathology measurements to within ▸ macroscopically visible spared submucosa (at least
1 mm.9 10 The degree of agreement was the best for the 1 mm or more) and fully intact MP—T1sm1/
earlier stage tumours; therefore, if the attempt is made to T1sm2;
make these measurements within the rectal wall, it is ▸ no submucosa preserved (<1 mm) with macroscopic-
logical to assume that the performance should be similar. ally intact fibres of outer layer of the MP—sm3/early
We therefore hypothesise that by using high-resolution T2.
MRI, it should be possible to identify tumour depth of
invasion within the rectal wall to enable identification of MRI technique
patients suitable for local excision approaches. The aim MR examinations were performed on a 1.5 T MR system
of this study was therefore to test the MRI diagnostic (Siemens) with a body-matrix coil centred over the
accuracy of ERC staging in terms of assessing the sub- pelvis. High-resolution T2w turbo spin echo (TSE) scans
mucosa, MP and the depth of tumour invasion within the were acquired in coronal and sagittal planes, followed by
rectal wall against the gold standard of histopathology in oblique-axial scans ( perpendicular to the long axis of
a cohort of patients prospectively staged in our institu- the rectum with 160 mm field of view (FOV), 3 mm slice
tion. The clinical impact of this assessment would deter- thickness, no interslice gap, a matrix of 256×256 and a
mine if the plane of excision needed to achieve a clear minimum of 4 number of signal averages (NSA)). No
deep margin proposed using the MRI is accurate enough contrast was used during MRI examination. No
for surgeons and endoscopists to plan their intervention diffusion-weighted images (DWI) were undertaken.
Open Access
Figure 1 (A) Submucosa has a hyperintense signal on MRI (red arrow) which should be considered partially or fully preserved
if at least 1 mm visible on high-resolution T2-WI. Findings confirmed on histopathology (B). (C) If no hyperintense signal present
between the tumour invasion portion and muscularis propria, full invasion of the submucosal layer should be considered.
Findings confirmed on histopathology (D).
Open Access
Figure 2 Flow chart demonstrating potential treatment algorithms based on MRI-defined endoscopic and surgical planes. Blue
colour indicates scenario 1 and pink colour indicates scenario 2.
In the final analysis, we calculated MRI accuracy for two accuracy of MRI in identifying patients with malignant
scenarios regardless of preoperative biopsy findings (scen- lymph nodes.
ario 1: feasibility of MRI to identify tumours with minimal The MRI scans were read by a second independent
submucosal invasion (≤T1sm2); scenario 2: feasibility of observer to measure interobserver agreement of MRI
MRI to identify tumours with no submucosal preservation staging accuracy of ERC. Anonymised scans were scored
but partial or full invasion of the MP (≤T2)). by the observer 2 who was blinded to the histopathology
In patients who had undergone total mesorectal resec- results and results of the MRI reports from the observer
tion during the evaluation period, we also compared the 1. All of the scans were analysed during three sessions
with 20±3 cases per session using the same reporting pro
forma as by the observer 1. Scans were staged according
Table 1 MRI vs histopathology in identifying rectal to the TNM classification and then categorised into
cancer with partial submucosal invasion (T1sm2 or less) three groups (≤T1sm2, ≤T2, >T2).
Histo ≤T1sm2 Histo >T1sm2
(A) Scenario 1
MR ≤T1sm2 True +ve False +ve Statistical analysis
MR >T1sm2 False −ve True −ve Data were tabulated and entered into a spreadsheet. All
statistical analyses were performed using Microsoft Excel
≤Histo T2 Histo >T2
V.14.4.5 (Redmond, Washington, USA 2011) and IBM
(B) Scenario 2 SPSS V.23.0 (IBM Corp, New York, USA, 2013).
≤MR T2 (≥1 mm True +ve False +ve The primary end point was the sensitivity, specificity
clear to MP)
and accuracy of MRI calculated for both scenarios.
MR T2 False −ve True −ve
MRI accuracy for staging and defining endoscopic and
(<1 mm clear to MP+)
surgical planes for local excision was calculated from
MP, muscularis propria.
histology data using cross tables. CIs for the sensitivity
Open Access
Figure 3 Diagram reporting flow of participants though the study (according to STARD recommendations).
and specificity for a binomial probability were calculated Overall 44 out of 65 patients underwent radical
using the exact method. surgery (table 3) and 22 were staged as T2 or less by
For those patients treated by TME, sensitivity analysis MRI. Pathological nodal status was positive in 7 out of 22
was performed to evaluate MRI accuracy in assessing patients, 4 of whom had been staged as node-positive on
lymph node status. MRI. Thus 15 out of 18 patients were correctly predicted
The hypothetical effect of an MRI-directed assessment as pT2 or less and pathology node-negative. Among the
of likely suitability for a local excision pathway rather 21 out of 65 (32%) patients undergoing local excision
than the actual MDT decision based predominantly on or TEM, 20 out of 21 were staged by MRI as T2 or less
clinical data was also calculated as a secondary end and confirmed as such by pathology. On follow-up, none
point. Differences in proportions of patients undergoing had lymph node relapse. If the decision had been made
radical surgery according to clinical assessment and pro- to offer local excision on MRI TN staging rather than
posed having radical resection according to MRI staging clinical assessment, a significant increase in organ pres-
were calculated using Newcombe method 10.12 ervation surgery from 32% to 58% would have been
For the interobserver agreement between the two radiol- observed (difference 26%, 95% CI 9% to 41%).
ogists, Cohens κ level was used to calculate results. A value In one case, AP resection was performed for a benign
of p<0.05 was chosen as the significance level for κ statis- large lower rectal adenoma, which was not proven to be
tics. The value of κ statistics was interpreted according to malignant on the preoperative biopsy but was clinically
Altman.13 Agreement lies between 0 and 1, where 0 is indi- too large and difficult for removal by local excision (the
cative of no agreement and 1 indicates complete agree- patient was counselled with regard to radical surgery for
ment. ‘Very good/near perfect’ agreement is considered a benign lesion).
as a κ of 0.81–1.00; ‘good’ agreement as a κ of 0.61–0.80;
‘moderate’ agreement as a κ of 0.41–0.60; ‘fair’ agreement Test results
as a κ of 0.21–0.40; and ‘poor’ agreement as a κ of <0.2. Results of MRI accuracy to predict safe resection plane
According to the table 4 results, MRI accuracy in identi-
fying a safe submucosal plane for non-invasive aden-
RESULTS omas, T1sm1-sm2 tumours (scenario 1—tumours
Participants ≤T1sm2) was 89% (95% CI 63% to 87%), sensitivity
Overall, 65 patients with a median age of 69 (34–91) ful- 71%, specificity 94%, PPV 77% and NVP 92%.
filled the MRI staging inclusion criteria of mrT3b or less When compared with histopathology data, MRI showed
(figure 3 presents a flow chart of participants according 89% (95% CI 79% to 95%) accuracy, 91% sensitivity, 85%
to STARD); demographics are presented in the table 2. specificity, 93% PPV and 81% NPV in identifying a safe
In 20% (13/65) of the patients, tumours were pre- MP plane, therefore differentiating tumour with full
operatively MR-categorised as lesions with no or minimal submucosal invasion but confined to MP versus tumour
invasion of the submucosal layer (no invasion, T1sm1, with spread beyond the MP (tumour ≤T2—scenario 2).
T1sm2). Of these 13 patients, 10 were confirmed as
such on pathology. Thirty-one patients (47%) had mr Results of interobserver agreement
T1sm3-T2 stage with no MR-evidence of tumour breach- Results of the κ statistic for the second observer when
ing through the MP. Of these 31 patients, 24 were compared with the central reviewer (observe 1) can be
proven to be pT1sm3-T2 on histopathology, and 21 seen in table 5. κ Agreement was calculated of value
patients had mrT stage >T2 with 17 out of 21 confirmed 0.734, with p<0.005 indicating a good agreement
to be pT3 disease. (weighted κ was 0.741).
Open Access
Open Access
and cannot be appropriately assessed in the absence of This has resulted in the review of the current standards
MP within the surgical specimen. Whenever the MP is of assessing such lesions. The emerging consensus is
lacking in the specimen, histopathological assessment of that rather than using a method with poor inter-observer
the submucosal depth invasion and differentiation of agreement, absolute measures of depth and width are
T1sm1/sm2 and even sm2/sm3 become challenging. It more reliable and therefore prognostically more
has also been stated that budding, lymphovascular inva- secure.20 It has also been shown that depth and width of
sion and tumour differentiation are prognostic factors mucosal invasion predict the lymph node metastasis in
that determine the need for either adjuvant therapy or ERC.21
subsequent completion/salvage surgery but the validity There is a paucity of good-quality data evaluating the
of these prognostic measures has been questioned performance of high-resolution MRI in staging ERC.
because of the lack of reproducibility of these factors. Traditionally, it has not been relied on as a primary tool
Table 4 MRI accuracy in identifying patients with minimal and full invasion of the submucosal layer when compared with
final histopathology
pT stage
mrT stage T0 T1sm1 T1sm2 T1sm3 T2 ≥T3a Total
Partial invasion of the submucosa mrT0,T1sm1,T1sm2 4 1 5 2 1 0 13
(scenario 1)
Full invasion of the submucosa, mrT1sm3-T2 0 0 4 7 17 3 31
partially or fully spared MP (scenario 2)
≥T3a-T3b 0 0 0 0 4 17 21
Total 4 1 9 9 22 20 65
Open Access
Open Access
Acknowledgements Authors thank Karen Thomas, Lead Statistician, 8. Brown G, Radcliffe AG, Newcombe RG, et al. Preoperative
The Royal Marsden Hospital, Sutton. assessment of prognostic factors in rectal cancer using
high-resolution magnetic resonance imaging. Br J Surg
Contributors All authors have contributed significantly. SB was involved in 2003;90:355–64.
conception of the study design, acquisition, analysis and interpretation of the 9. Taylor FG, Quirke P, Heald RJ, et al. Preoperative high-resolution
data, and drafting the manuscript. JR and AW contributed to acquisition and magnetic resonance imaging can identify good prognosis stage I, II,
and III rectal cancer best managed by surgery alone: a prospective,
interpretation of the data. SR, PT and DC revised the manuscript critically for
multicenter, European study. Ann Surg 2011;253:711–9.
the intellectual content. DT conceptualised the study design and revised the 10. Taylor FG, Quirke P, Heald RJ, et al. One millimetre is the safe
manuscript critically for the intellectual content. GB conceptualised the study cut-off for magnetic resonance imaging prediction of surgical margin
design, revised the manuscript critically for the intellectual content, and status in rectal cancer. Br J Surg 2011;98:872–9.
approved the final version to be published. 11. Taylor FG, Swift RI, Blomqvist L, et al. A systematic approach to the
interpretation of preoperative staging MRI for rectal cancer. AJR Am
Funding This study was supported by the Biomedical Research Centre. J Roentgenol 2008;191:1827–35.
12. Newcombe RG. Interval estimation for the difference between
Competing interests None declared. independent proportions: comparison of eleven methods. Stat Med
1998;17:873–90.
Patient consent Obtained.
13. Altman DG. Practical statistics for medical research. Boca Raton,
Ethics approval Local research and development office. FL: Chapman & Hall/CRC. xii, 611p, 1999.
14. Logan RF, Patnick J, Nickerson C, et al. Outcomes of the Bowel
Provenance and peer review Not commissioned; externally peer reviewed. Cancer Screening Programme (BCSP) in England after the first
1 million tests. Gut 2012;61:1439–46.
Data sharing statement No additional data are available. 15. Garcia-Aguilar, J., Holt A. Optimal management of small rectal
cancers: TAE, TEM, or TME? Surg Oncol Clin N Am 2010;19:743–60.
Open Access This is an Open Access article distributed in accordance with 16. Langer C, Liersch T, Süss M, et al. Surgical cure for early rectal
the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, carcinoma and large adenoma: transanal endoscopic microsurgery
which permits others to distribute, remix, adapt, build upon this work non- (using ultrasound or electrosurgery) compared to conventional local
commercially, and license their derivative works on different terms, provided and radical resection. Int J Colorectal Dis 2003;18:222–9.
the original work is properly cited and the use is non-commercial. See: http:// 17. Moore JS, Cataldo PA, Osler T, et al. Transanal endoscopic
microsurgery is more effective than traditional transanal excision for
creativecommons.org/licenses/by-nc/4.0/
resection of rectal masses. Dis Colon Rectum 2008;51:1026–30;
discussion 1030-1.
18. Marusch F, Ptok H, Sahm M, et al. Endorectal ultrasound in rectal
REFERENCES carcinoma--do the literature results really correspond to the realities
1. Muto T, Bussey HJ, Morson BC. The evolution of cancer of the colon of routine clinical care? Endoscopy 2011;43:425–31.
and rectum. Cancer 1975;36:2251–70. 19. Haboubi N, Salmo E. Are we accurately measuring the depth of the
2. Greenaway KJH, Khatun S, Kuryba A, et al. National Bowel Cancer submucosal invasion in early colorectal cancer by equating the
Audit Report 2015. Kikuchi submucosa levels with distances measured in fractions of a
3. Ashraf S, Hompes R, Slater A, et al. A critical appraisal of endorectal millimetre? Colorectal Dis 2013;15:775–7.
ultrasound and transanal endoscopic microsurgery and 20. Davenport A, Morris J, Pritchard SA, et al. Interobserver variability
decision-making in early rectal cancer. Colorectal Dis 2012;14: amongst gastrointestinal pathologists in assessing prognostic
821–6. parameters of malignant colorectal polyps: a cause for concern.
4. Williams JG, Pullan RD, Hill J, et al. Management of the malignant Tech Coloproctol 2016;20:647–52.
colorectal polyp: ACPGBI position statement. Colorectal Dis 2013;15 21. Toh EW, Brown P, Morris E, et al. Area of submucosal invasion and
(Suppl 2):1–38. width of invasion predicts lymph node metastasis in pT1 colorectal
5. Videhult P, Smedh K, Lundin P, et al. Magnetic resonance imaging cancers. Dis Colon Rectum 2015;58:393–400.
for preoperative staging of rectal cancer in clinical practice: high 22. Balyasnikova S, Read J, Tait D, et al. The results of local excision
accuracy in predicting circumferential margin with clinical benefit. with or without postoperative adjuvant chemoradiotherapy for early
Colorectal Dis 2007;9:412–19. rectal cancer among patients choosing to avoid radical surgery.
6. Kim NK, Kim MJ, Park JK, et al. Preoperative staging of rectal Colorectal Dis 2017;19:139–47.
cancer with MRI: accuracy and clinical usefulness. Ann Surg Oncol 23. Habr-Gama A, Perez RO, Nadalin W, et al. Operative versus
2000;7:732–7. nonoperative treatment for stage 0 distal rectal cancer following
7. Giusti S, Buccianti P, Castagna M, et al. Preoperative rectal cancer chemoradiation therapy: long-term results. Ann Surg 2004;240:
staging with phased-array MR. Radiat Oncol 2012;7:29. 711–17; discussion 717-8.
These include:
References This article cites 21 articles, 1 of which you can access for free at:
http://bmjopengastro.bmj.com/content/4/1/e000151#ref-list-1
Open Access This is an Open Access article distributed in accordance with the Creative
Commons Attribution Non Commercial (CC BY-NC 4.0) license, which
permits others to distribute, remix, adapt, build upon this work
non-commercially, and license their derivative works on different terms,
provided the original work is properly cited and the use is
non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Email alerting Receive free email alerts when new articles cite this article. Sign up in the
service box at the top right corner of the online article.
Notes